Areas Pierre Mainville is Knowledgeable in:
GENERIC DRUGS, NEW DRUG ENTITIES, CHRONIC PAIN DRUG
Techniques Pierre Mainville Uses:
I'M THE OWNER OF A PATENTED DRUG FORMULATION Re: Patented formulation US 7,855,196 B2 Date dec 21 2010 and Canadian Patent Pending no: 2,556,163 FOR CHRONIC NEUROPATHIC PAIN AS A PRIMARY INDICATION AND AS SECONDARY INDICATION FOR TINNITUS THIS A 2 DRUG FORMULATION : AN AGONIST AND ANTAGONIST TO MODULATE UNDESIRABLE SIDE EFFECTS AND UPREGULATE RECEPTORS
Pierre Mainville's Problem Solving Skills:
- FIND INNOVATIVE SOLUTION CREATIVE
Pierre Mainville's Problem Solving Experience:
- USE BENZODIAZEPINE DRUG MORE EFFECTIVELY WITH MUCH LESS SIDE EFFECTS PREVENT TOLERANCE SEDATION